Evidence map›Paper›PMID 41623652›Full record

ArticleAccess microbiology2026

Assessment of pathogenic potential in non-pathogenic industrially relevant bacteria.

Katrine Nøhr-Meldgaard, Carsten Struve, Hanne Ingmer, Yvonne Agersø

Abstract read
In one paragraph

Article in Access microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katrine Nøhr-MeldgaardChr. Hansen A/S, Hørsholm, Denmark. Now Novonesis A/S, Lyngby, Denmark.
Carsten StruveChr. Hansen A/S, Hørsholm, Denmark. Now Novonesis A/S, Lyngby, Denmark.
Hanne IngmerDepartment of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.
Yvonne AgersøChr. Hansen A/S, Hørsholm, Denmark. Now Novonesis A/S, Lyngby, Denmark.ORCID https://orcid.org/0000-0002-5560-8158

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Assessment of the pathogenic potential (virulence and toxicity) in non-pathogenic bacterial species is a challenge as it relies on methods developed for assessment of species known to be pathogenic. Here, we have applied and evaluated some of these methods on industrially relevant bacteria to differentiate between 'true' virulence factors applying only to pathogens and niche factors being defined as promoting colonization and survival rather than pathogenicity and as being present also in non-pathogenic bacteria. We examined the pathogenicity of 49 strains from 9 industrially relevant bacterial species (

Indexed as

lactic acid bacteriapathogenicityvirulence

Identifiers

PMID41623652
PMCPMC12859219

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.